Six-month Efficacy of Pfizer/BioNTech COVID-19 Vaccine in Patients With Solid Tumors Similar to General Population
PHILADELPHIA – Six months after receiving their second dose of the BNT162b2 vaccine (Comirnaty), patients with solid tumors retained...